Kalpana Kalpana

Asunaprevir

Updated on
Share on FacebookTweet on TwitterShare on LinkedIn
Asunaprevir fixhepccommediacomacymailinguploadasunaprevi

Asunaprevir daclatasvir national patient consultation webinar


Asunaprevir (formerly BMS-650032, brand name in Japan and Russia Sunvepra) is an experimental drug candidate for the treatment of hepatitis C. It is undergoing development by Bristol-Myers Squibb and is currently in Phase III clinical trials.

Contents

Asunaprevir is an inhibitor of the hepatitis C virus enzyme serine protease NS3.

Asunaprevir is being tested in combination with pegylated interferon and ribavirin, as well as in interferon-free regimens with other direct-acting antiviral agents including daclatasvir.

How to pronounce asunaprevir


References

Asunaprevir Wikipedia


Similar Topics
The Dollar a Year Man
Dianne Reeves
Dave Hartnett
Topics